New formyl peptide has the stimulating properties in point of immune system cells by Martynov, A. V. et al.
Annals of Mechnikov Institute, N 3, 2017 
www.imiamn.org.ua /journal.htm                                                                 62 
 
DOI: 10.5281/zenodo.1000146 
UDC 619:616.98:578.828.11-078 
 
NEW FORMYL PEPTIDE HAS THE 
STIMULATING PROPERTIES IN POINT OF 
IMMUNE SYSTEM CELLS 
 
«Mechnikov Institute of Microbiology and 
Immunology National Academy of Medical Sciences of 
Ukraine» 
 
Martynov A. V., Romanova E. A., Pohorila M. S., 
Shcherbak O. M., Sidorenko T. A., Igumnova N. I., 
Yukhimenko V. I. 
 
Introduction 
Tuberculosis infection (TBI) is still one of the major 
health problems, despite of global intensive medical and 
pharmaceutical efforts [1]. At nowadays TBI is 
responsible for 1,3 million death all over the world. As it 
is known, in the majority of immunocompetent 
individuals TBI is repressed by immune system, and as a 
result we can observe the latent TBI. The main danger 
hides in unpredictable activation process of latent TBI 
determining the spreading of infection among population 
[2]. But recent study gives a good chance for restriction of 
TBI distribution, which suggested that early infection may 
be eradicated in a part of individuals [3].Only fewer than 
10 % of infected individuals shows the clinically evident 
of primary TBI, and the majority of them are able to 
contain the primary infection with the granulomas 
formation, which consist of lymphocytes and M. 
tuberculosis infected macrophages [4]. Few weeks after, 
as we know, granulomas undergo necrosis resulting in the 
death of the majority of M. tuberculosis. But the small 
proportion of bacilli that survived has been postulated to 
result in latent TBI [5].  
 So, our study is focused on finding new 
medicinal preparations and combining them into aerosol 
pharmaceutical form which has the aim to complete the 
phagocytosis of absorbed M. tuberculosis by 
macrophages, that can prevent the activation of latent 
TBI.  
 Now we investigate the ability of new formyl 
peptide to stimulate phagocytosis completion in vivo. 
This strategy is explained by the key role of the 
phagocytosis completion in preventing long-term 
persistence of M. tuberculosis in macrophage.  
 Formyl peptides are released by microbes and 
damaged tissues that are perceived as danger signals and 
is recognized by the innate immune system by formyl 
peptides receptors expressed on neutrophil granulocytes 
[6, 7]. Of course, the outcome of the continuously 
ongoing with invading microorganisms is possible due to 
the chemotactic potency of neutrophils, which can 
migrate in response to gradients of chemoattractants [8]. 
The formyl peptides potency as neutrophil 
chemoattractants was discovered in the middle of 1970ʼs. 
Recent studies show that activated formyl peptide 
receptors (FPR1 and FPR2) trigger a variety of functions, 
including chemotaxis, degranulation, ROS (reactive 
oxygen) production and phagocytosis [9]  
 Aim To assess the exposure to new formyl 
peptides on blood cells count and imunocompetent cells 
functional activity in immunodepressed mice with BCG 
injection.  
 
Materials and Methods 
 
Animals 
The ability of new formyl peptide to activate the 
completeness of phagocytosis by peritoneal macrophages 
absorbed by them was evaluated in vivo. For reaching the 
aim of the study we have used peritoneal macrophages 
obtained from white laboratory male mice 2 months of 
age, and weight - 22 ± 2 g. Total of 36 animals were 
randomized on 4 groups: 
1 Group – (Control) - mice with NaCl solution (0,9 %) 
injection, (n=11), 
2 Group – mice with dexamethasone injection, (n=11), 
3 Group - mice with dexamethasone and BCG injection, 
(n=11), 
4 Group - mice with dexamethasone, BCG and formyl 
peptide injection, (n=11).  
 
 Animals were kept in vivarium of "Mechnikov 
institute of Microbiology and Immunology of NAMS of 
Ukraine" on a standard diet with specified conditions of 
animal management. Work with laboratory animals was 
performed according to the rules [10].  
 
Assessment of immune cells function activity 
 
Staphylococcus phagocytosis test 
This test relies on the uptake of heat-
killed Staphylococcus aureus by macrophages over a brief 
period of time. The cell pellet was resuspended in 3 ml 
RPMI 1640 medium and the number of macrophages was 
determined in a Goryaevʼs chamber to bring the cell 
concentration in the medium to 1 × 106 / mL [11]. 
 Heat-killed S. aureus suspended in phosphate-
buffered saline was adjusted to ×106  cells/mL and stored 
at –20°C. A 0,1mL of Hank's balanced salt solution, a 
0,1mL of pooled serum, and a 0,1 mL of heat-killed S. 
aureus were added to 0,2 mL of buffy coat and then 
centrifuged for 5 min at 15000 rpm. The supernatant was 
removed. Then the sediment was smeared, fixed with 
methanol, stained with Romanowsky-Gimza stain and 
viewed under microscope with immersion (100×). 100 
macrophages were counted. Number of  S. aureus-
engulfed macrophages were counted as positive cells. 
Phagocytic Index = Number of positive cells/100 cells. 
Lytic index = Total number of S. aureus/100. 
 
Reaction of lymphocyte transformation 
Proliferative activity of lymphocytes was 
assessed by the level of their spontaneous and FGA-
induced transformations in vitro (RBTL) [11]. The 
intensity of cell proliferation was assessed 
morphologically by the presence of blast forms appearing 
at the end of cultivation by using the light microscopy. 
The cells were cultured for 72 hours in RPMI-1640, with 
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CO2 (5%). The FGA was introduced into the culture 
medium at a dose of 10 μg/mL. 
 
Level of receptor’s expression on lymphocytes 
Level of receptor’s expression on lymphocytes 
was examined in reaction of lymphocytes rosette 
formation with sheep red blood cells. Lymphocytes were 
obtained from the peripheral blood of mice by using ficoll 
velocity sedimentation gradient. 0,1 mL of isolated cells 
suspension (2×106/mL) was mixed with 0,1 mL of a 0,5% 
suspension of sheep red blood cells, incubated at T = 
37°C for 10 min. Then the mixture was centrifuged for 5 
min at 1000 rpm and incubated at T=4°C for an hour. 
Rosettes were fixed by adding to the each tube 0,05 mL of 
gluteraldehyde solution (3 %). After resuspension, they 
were left at room temperature for 20 min. At the end of 
this period, 5 mL of distilled water were added to the 
tubes, mixed gently and centrifuged at 1000 rpm for 10 
min. The supernatant was removed, and slides were 
prepared from the sediment. After drying, the slides were 
fixed in 96% ethanol and stained by Romanowsky-Gimza. 
In each preparation 200 cells were counted, determining 
the percentage of lymphocytes that formed rosettes with 3 
or more red blood cells [11]. 
 
Amount of blood cells 
 The number of different types of cariocytes in 
the leukogram was counted morphologically using the 
light microscope «Primo Star» (Carl Zeiss, Germany), 
taking into account not less than 200 cells in the 
preparation stained with Romanowsky-Gimza stain) [11]. 
 
Statistical analysis 
The data were analyzed using SPSS software. 
Results of the numerical data are expressed as mean and 
standard deviation. Statistical significance was 
determined by using unpaired t test and one way 
ANOVA. p< 0,05 was taken as the level of significance) 
[12]. 
 
Results and Discussion  
 Our previous study, ex vivo experiments in mice, 
has revealed that the administration of dexamethasone 
before the introduction of BCG makes it possible to 
obtain a model for reducing the frequency of completion 
of phagocytosis by alveolar macrophages of adsorbed 
mycobacteria of the vaccinal strain [13]. In this paper, we 
used this approach to demonstrate the immunotrophy of a 
new synthetic formyl peptide in vivo. 
 The introduction of dexamethasone before the 
intraperitoneal administration of BCG led to decreased 
phagocytic index of peritoneum macrophages by 34 %, 
lytic index of peritoneum macrophages – by 76,8 %. 
 
 
Tabl. 1 – Exposure to new formyl peptide on imunocompetent cells functional activity in immunodepressed mice 
with BCG injection, (m±σ) 
          Variables 
 
 
 
Groups of animals 
Phagocytic Index 
of peritoneum 
macrophages (PI), 
% 
Lytic Index of 
peritoneum 
macrophages  
LT stimulated 
FGA, % 
LT 
spontaneous, 
% 
Level of 
receptor’s 
expression on 
lymphocytes, 
% 
Control (NaCl 0,9 % 
solution) 
68,7±2,1 7,3±0,5 67,41±3,18 18,34±1,52 27,9±1,72 
BCG  65,2±3,0 6,9±0,42 69,82±4,06 30,40±2,7 1) 38,66±2,19 1) 
BCG + Dexamethasone 43,18±2,6 1) 1,6±0,52 1) 36,51±3,42 8,04±0,52 1) 9,07±0,86 1) 
BCG + Dexamethasone 
+ Formyl peptide 
(16,7%) 1:10 
62,9±2,9 1), 2) 5,7±0,50 1), 2) 52,34±3,77 1), 2) 15,46±1,22 2) 24,3±2,0 
1) – compared with control, (n=11), (p<0,05). 2) - compared with group of animals with BCG + Dexamethasone 
injections, (n=11), (p<0,05). 
 
 The introduction of the new formyl peptide to 
mice injected with BCG and dexamethasone promoted the 
increasing of the phagocytic activity of peritoneal 
macrophages. The phagocytic index in this group has no 
statistically difference with the control group. The lytic 
index has not reached the physiological norm - (5,7 ± 
0,50) vs (7,3 ± 0,5), but was significantly higher (3,6 
times) compared to the group of mice that have not 
obtained the formyl peptide after BCG and 
dexamethasone administration, (p<0,05). 
As well as, we have observed the ex vivo 
enhancing of FGA-stimulated (by 1,4 times) and 
spontaneous lymphocyte transformation (by 1,8 times) 
after the formyl peptide’s administration compared to the 
group without formyl peptide administration, (p<0,05). 
Also, should be highlighted recent data, which 
suggested that new formyl peptide is able to promote the 
expression of receptors on lymphocytes. As we can see, 
the percent of receptors expression on lymphocytes have 
raised by 2,7 times after the formyl peptide's 
administration in mice with BCG and dexamethasone 
injections and was comparable with normal control, 
(Tabl. 1). 
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Tabl. 2 – Exposure to new formyl peptide on blood cell’s count in immunodepressed mice with BCG injection, 
(m±σ) 
           Variables 
 
 
 
 
Group of animals 
Total leucocyte 
count, 109/л 
Eosinophil,  
% 
Banded 
neutrophil,% 
Segmented 
neutrophil,% 
Monocyte, % Lymphocyte, % 
Control (NaCl 0,9% 
solution) 
5,17±0,31 3,01±0,2 3,06±0,28 35,4±2,81 6,02±0,4 53,20±0,37 
BCG  5,21±0,22 5,1±0,371) 15,10±0,411) 27,2±1,61) 12,0±0,171) 34,56±0,411) 
BCG + 
Dexamethasone 
3,10±2,601) 6,51±0,431) 8,09±0,321) 28,03±1,821) 10,1±0,721) 44,18±0,321) 
BCG + 
Dexamethasone + 
formyl peptide (16,7 
%) 1:10 
4,81±0,32) 2,40±0,522) 5,46±1,221),2 30,5±2,212) 6,20±0,622) 49,87±0,262) 
1) – compared with control, (n=11), (p<0,05). 2) – compared with group of animals with BCG + Dexamethasone 
injections, (n=11), (p<0,05). 
 
The investigation of blood cell count showed that 
formyl peptide administration gave rise of total leucocyte 
count (by 1,5 times), which was decreased after 
dexamethasone applying. Percent of eosinophil in 
peripheral blood was significantly lower compared to the 
group with dexamethasone and BCG injections and 
reached the norm in this group. 
BCG injection caused the significant growth in 
banded neutrophil's count - by 15 times - compared to the 
normal level. Dexamethasone administration with BCG 
has led to the similar effect, but in some lower degree – 
increase by 8 times. Formyl peptides exposure came out 
in banded neutrophils reliable count decreasing compared 
to the respective control – (5,46±1,22) % versus 
(8,09±0,32) %, (p<0,05). 
BCG injection has led to the decline in reliable 
count of segmented neutrophils (by 1,3 times) comparing 
with control. There were no reliable difference in data 
between two groups of mice - with Dexamethasone and 
BCG administration and only BCG administration in 
count of segmented neutrophils. When under the 
influence of formyl peptide injections the reliable count of 
segmented neutrophils was commensurate with normal 
control. 
The BCG and dexamethasone injections have 
caused increasing the monocyte level – (10,1±0,72) % vs 
(6,02±0,4) % and decreasing of lymphocyte level – 
(44,18±0,32) % vs (53,20±0,37) %, (p<0,05)б which was 
corrected by formyl peptide administration – (6,20±0,62) 
% and (49,87±0,26) % with no statistical differences with 
observed levels of monocytes and lymphocytes in normal 
control group. 
 
Conclusions 
The introduction of the new formyl peptide to 
mice injected with BCG and dexamethasone promoted 
increasing of the phagocytic activity of peritoneal 
macrophages. What is demonstrated by significantly 
growing of phagocytic and lytic indexes in this group 
compared to the group of mice that have not obtained the 
formyl peptide after BCG and dexamethasone 
administration, (p<0,05).  
Also, was observed the ex vivo enhancing of 
FGA-stimulated (by 1,4 times) and spontaneous 
lymphocyte transformation (by 1,8 times) after the formyl 
peptide’s administration compared to the appropriate 
control group, (p<0,05). 
New formyl peptide is able to promote the 
expression of receptors on lymphocytes. The percent of 
receptors expression on lymphocytes has raised by 2,7 
times after the formyl peptide's administration in mice 
with BCG and dexamethasone injections.  
The formyl peptide administration normalizes 
the blood cells count compared to the appropriate control 
group, where the total count of leucocytes was decreased 
and ratio of neutrophils, lymphocytes and eosinophils 
were characterized by a disproportion. 
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NEW FORMYL PEPTIDE HAS THE 
STIMULATING PROPERTIES IN POINT OF 
IMMUNE SYSTEM CELLS 
Martynov A. V., Romanova E. A., Pohorila M. S., 
Shcherbak O. M., Sidorenko T. A., Igumnova N. I., 
Yukhimenko V. I. 
Introduction Tuberculosis infection (TBI) is still one of 
the major health problems, despite of global intensive 
medical and pharmaceutical efforts as it is known, in the 
majority of immunocompetent individuals TBI is 
repressed by immune system, and as a result we can 
observe the latent TBI. The main danger hides in 
unpredictable activation process of latent TBI determining 
the spreading of infection among population. Now we 
investigate the ability of new formyl peptide to stimulate 
phagocytosis completion in vivo. This strategy is 
explained by the key role of the phagocytosis completion 
in preventing long-term persistence of M. tuberculosis in 
macrophage.  
Formyl peptides are released by microbes and 
damaged tissues that are perceived as danger signals and 
is recognized by the innate immune system by formyl 
peptides receptors expressed on neutrophil granulocytes. 
Recent studies show that activated formyl peptide 
receptors (FPR1 and FPR2) trigger a variety of functions, 
including chemotaxis, degranulation, ROS (reactive 
oxygen) production and phagocytosis. 
Materials and methods The ability of new 
formyl peptide to activate the completeness of 
phagocytosis by peritoneal macrophages absorbed by 
them was evaluated in vivo. For reaching the aim of the 
study we have used peritoneal macrophages obtained 
from white laboratory male mice 2 months of age, and 
weight - 22 ± 2 g. Total of 36 animals were randomized 
on 4 groups:1 Group – (Control) - mice with NaCl 
solution (0,9 %) injection, (n=11), 2 Group – mice with 
dexamethasone injection, (n=11), 3 Group - mice with 
dexamethasone and BCG injection, (n=11), 4 Group - 
mice with dexamethasone, BCG and formyl peptide 
injection, (n=11). Animals were kept in vivarium of 
"Mechnikov institute of Microbiology and Immunology 
of NAMS of Ukraine" on a standard diet with specified 
conditions of animal management. Work with laboratory 
animals was performed according to the rules. The 
peritoneum macrophages functional activity was assessed 
by using Staphylococcus phagocytosis test, proliferative 
activity of lymphocytes - by the level of their spontaneous 
and FGA-induced transformations in vitro (RBTL), level 
of receptor’s expression on lymphocytes was examined in 
reaction of lymphocytes rosette formation with sheep red 
blood cells. The number of different types of cariocytes in 
the leukogram was counted morphologically using the 
light microscope «PrimoStar» (Carl Zeiss, Germany), 
taking into account not less than 200 cells in the 
preparation stained with Romanowsky-Gimza stain. 
Statistical significance was determined by using 
unpaired t test and one way ANOVA. p< 0,05 was taken 
as the level of significance. Results and discussion The 
introduction of the new formyl peptide to mice injected 
with BCG and dexamethasone promoted increasing of the 
phagocytic activity of peritoneal macrophages. What is 
demonstrated by significantly growing of phagocytic and 
lytic indexes in this group compared to the group of mice 
that has not obtained the formyl peptide after BCG and 
dexamethasone administration, (p<0,05). Also, was 
observed the ex vivo enhancing of FGA-stimulated (by 
1,4 times) and spontaneous lymphocyte transformation 
(by 1,8 times) after the formyl peptide’s administration 
compared to the appropriate control group, (p<0,05). New 
formyl peptide is able to promote the expression of 
receptors on lymphocytes. The percent of receptors 
expression on lymphocytes has raised by 2,7 times after 
the formyl peptide's administration in mice with BCG and 
dexamethasone injections. The formyl peptide 
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administration has led to the normalization of blood cells 
count, when their depletion after dexamethasone and 
BCG injection has taken place. Conclusions The new 
formyl peptide administration to mice injected with BCG 
and dexamethasone promotes increasing of the phagocytic 
activity of peritoneal macrophages, enhance the FGA-
stimulated and spontaneous lymphocyte transformation, 
enhances the level of receptors expression on 
lymphocytes compared with to the group of mice that has 
not obtained the formyl peptide after BCG and 
dexamethasone injection, (p<0,05). The formyl peptide 
administration normalizes the blood cells count compared 
to the appropriate control group, where the total count of 
leucocytes was decreased and ratio of neutrophils, 
lymphocytes and eosinophils were characterized by a 
disproportion. 
Key words: tuberculosis infection, formyl-peptides, 
immune system cells, phagocytosis, immunosuppression, 
experiment. 
 
